Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.78
+0.15 (1.29%)
At close: Mar 9, 2026, 4:00 PM EDT
11.25
-0.53 (-4.50%)
After-hours: Mar 9, 2026, 6:49 PM EDT
Elicio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 206 | 55 | 80 | - | - | - | |
| Market Cap Growth | 111.11% | -31.39% | - | - | - | - | |
| Enterprise Value | 199 | 55 | 72 | - | - | - | |
| Last Close Price | 11.63 | 5.10 | 8.34 | - | - | - | |
| PB Ratio | 52.60 | -4.86 | 7.04 | - | - | - | |
| P/TBV Ratio | 53.58 | - | 7.04 | - | - | - | |
| Debt / Equity Ratio | 3.95 | -2.30 | 0.61 | 0.84 | -2.88 | 0.03 | |
| Net Debt / Equity Ratio | -1.45 | -0.74 | -0.53 | 0.15 | -0.61 | -0.89 | |
| Net Debt / EBITDA Ratio | 0.13 | -0.19 | 0.17 | -0.06 | -0.10 | 0.94 | |
| Net Debt / FCF Ratio | 0.14 | -0.23 | 0.18 | -0.06 | -0.10 | 0.86 | |
| Quick Ratio | 3.16 | 1.53 | 1.32 | 0.90 | 0.49 | 4.53 | |
| Current Ratio | 3.30 | 1.80 | 1.68 | 1.56 | 0.55 | 4.67 | |
| Return on Equity (ROE) | - | -170157.38% | -346.95% | -1170.93% | -430.76% | -136.60% | |
| Return on Assets (ROA) | -79.40% | -101.64% | -89.70% | -79.16% | -92.36% | -68.96% | |
| Return on Capital Employed (ROCE) | -194.50% | -270.10% | -205.50% | -150.20% | 626.30% | -96.10% | |
| Earnings Yield | -22.43% | -94.42% | -43.93% | - | - | - | |
| FCF Yield | -19.05% | -67.60% | -40.89% | - | - | - | |
| Buyback Yield / Dilution | -35.90% | -141.35% | -1500.08% | 97.93% | -42.39% | -172.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.